Broderick Brian C lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 22,761 shares of the healthcare conglomerate's stock after acquiring an additional 1,264 shares during the period. UnitedHealth Group makes up 2.3% of Broderick Brian C's investment portfolio, making the stock its 20th biggest position. Broderick Brian C's holdings in UnitedHealth Group were worth $11,514,000 as of its most recent filing with the SEC.
A number of other large investors have also added to or reduced their stakes in UNH. State Street Corp raised its position in UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the period. Geode Capital Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after acquiring an additional 319,515 shares during the last quarter. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter worth approximately $6,375,744,000. Franklin Resources Inc. lifted its position in UnitedHealth Group by 10.7% in the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 0.5% in the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after purchasing an additional 36,394 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of several analyst reports. Oppenheimer increased their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, KeyCorp reaffirmed an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Buy" and an average price target of $629.32.
Get Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Down 2.9 %
UnitedHealth Group stock traded down $15.50 during trading hours on Friday, hitting $524.94. The stock had a trading volume of 9,914,705 shares, compared to its average volume of 4,256,040. The stock has a market capitalization of $480.17 billion, a P/E ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50-day moving average price is $509.24 and its 200-day moving average price is $542.12. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the company earned $5.83 EPS. The company's quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group's dividend payout ratio is currently 54.19%.
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company's stock.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report